Hib ACIP Vaccine Recommendations (Haemophilus Influenzae type B) 

as Published in Morbidity and Mortality Weekly Report (MMWR)

CURRENT Hib Vaccine Recommendations

• MMWR, April 29, 2016, Vol 65, #16
  Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series
  Print version [2 pages]

• MMWR, February 28, 2014, Vol 63, #RR01
  Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the ACIP, 2014
  Print version [20 pages]
• See also:
  • ACIP-VFC Resolution

ARCHIVED Hib Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, September 18, 2009, Vol 58, #36
  Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
  Print version [1.78MB, 36 pages]
• MMWR, June 26, 2009, Vol 58, #24
  Updated Recommendations for Use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months
  Print version [1.28MB, 28 pages]
• MMWR, December 21, 2007, Vol 56, #50
  Interim Recommendations for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB® and Comvax®)
  Print version [28 pages]
• MMWR, September 17, 1993, Vol 42, #RR-13
  Recommendations for Use of Haemophilus b Conjugate Vaccines and a Combined Diphtheria, Tetanus, Pertussis, and Haemophilus b Vaccine
  • Print version [22 pages]
• MMWR, January 11, 1991, Vol 40, #RR01
  Haemophilus b Conjugate Vaccines for Prevention of Haemophilus influenzae Type b Disease Among Infants and Children Two Months of Age and Older (.pdf version not available)

Top of Page